Seeing Is Believing
Currently out of the existing stock ratings of Douglas Tsao, 457 are a BUY (83.7%), 4 are a SELL (0.73%), 85 are a HOLD (15.57%).
Analyst Douglas Tsao, carries an average stock price target met ratio of 35.29% that have a potential upside of 25.97% achieved within 162 days. Previously, Douglas Tsao worked at HC WAINWRIGHT.
Douglas Tsao’s has documented 1,032 price targets and ratings displayed on 47 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PTGX, Protagonist Therapeutics at 03-Jun-2025.
Analyst best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) at 3/7/2025. The price target of $54 was fulfilled within 3 days with a profit of $15.65 (40.81%) receiving and performance score of 136.03.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$5
$1.24 (32.98%)
$18
4 years 1 months 2 days ago
(05-May-2021)
0/6 (0%)
$1.02 (25.63%)
Buy
$12
$8.24 (219.15%)
$10
4 years 3 months 6 days ago
(01-Mar-2021)
2/6 (33.33%)
$8.01 (200.75%)
651
Buy
$15
$11.24 (298.94%)
$19
4 years 4 months 28 days ago
(10-Jan-2021)
0/9 (0%)
$10.93 (268.55%)
Which stock is Douglas Tsao is most bullish on?
Which stock is Douglas Tsao is most reserved on?
What Year was the first public recommendation made by Douglas Tsao?